HCPCS Q2055 at Providence Holy Family Hospital
Idecabtagene vicleucel, up to 510 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
What Providence Holy Family Hospital publishes for this code: as an outpatient
| Who pays | Hospital’s fee (lowest – highest) | Doctor’s fee the hospital lists |
|---|---|---|
| Commercial insurance | $484,690 – $1,723,006 | — |
| Medicare Advantage | $559,781 – $615,759 | — |
| Cash price | — | — |
| List price | — | — |
Bills to expect
The hospital’s fee is the price above. Doctors usually send their own bills. Their amounts here are what original Medicare allows in the rest of Washington for 2026, and a private-plan estimate of 118% to 179% of that (the range found across studies of what insurers pay doctors). Those are estimates, not quotes.
| Bill | What it’s for | Original Medicare allows | Private plan estimate |
|---|---|---|---|
| Hospital's fee | The drug, per billing unit | — | The price above |
Compare HCPCS Q2055 at every Washington hospital, with Medicare’s reference amounts.